Search Search

Featured Research

Through impactful research findings, publications and clinical trials, researchers at the Center for Respiratory Biology and Therapeutics are global leaders in innovative therapies aiming to transform treatment of pediatric respiratory diseases.

Learn about the wide range of pediatric respiratory research center members are investigating.

A Fresh Breath For Respiratory Research

A center at Seattle Children’s Research Institute aims to pioneer treatments, advance technologies and refine surgical approaches for respiratory conditions.

Far-Reaching Effects of Wildfire Smoke Exposure

Dr. Mary Crocker, pediatric pulmonologist and researcher at the research institute’s Center for Respiratory Biology and Therapeutics, shares with On the Pulse insights into her research and how to protect kids from indoor and outdoor pollutants. Read more.

Creation of a Cystic Fibrosis-Specific Antibiotic Spectrum Index as an Antimicrobial Stewardship Initiative

Researchers created a cystic fibrosis (CF)-specific antibiotic spectrum index (ASI) to guide future CF research studies in optimizing antibiotic selection for patients.

Airway Cells in Children With Allergic Asthma Protect Against COVID-19 Infection

Seattle Children’s researchers and colleagues discovered why kids with allergic asthma fare better against COVID-19.

Center for Respiratory Biology and Therapeutics

For questions or inquiries,
email: CRBT@seattlechildrens.org.

Physical Address

1900 Ninth Ave.
Seattle, WA 98101

Mailing Address

M/S JMB-7
PO Box 5371
Seattle, WA 98145-5005

Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.